- Priced an upsized $500 million offering of common stock and convertible senior notes.
Viking Therapeutics priced an upsized $500M offering of common stock and convertible senior notes. The offering will increase outstanding shares and add convertible debt, diluting existing holders.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.